Alison Zhang

Pembrolizumab and Denosumab in Clear-Cell Renal-Cell Carcinoma.

Carole A. Harris, Danka Sinikovic Zebic, Michelle Frances Morris, Tom Ferguson et autres

BACKGROUND: Anti-PD1 immune checkpoint inhibitors (ICI) are effective in clear-cell renal-cell carcinoma (ccRCC). Preliminary data suggest inhibition of Receptor Activator of Nuclear Factor-κB Ligand (RANKL) signaling may potentiate ICI efficacy. We evaluated the activity and safety of the RANKL-inhibitor denosumab with pembrolizumab …

au (code pays fourni par la source)

Patient and Physician Preferences for Treatment in Advanced Renal Cell Carcinoma in Asia-Pacific (PEAR)- A Discrete Choice Experiment

Alison Zhang, Niara Oliveira, Bo Li, Inkeun Park et autres

au, hk, kr, gb, us, de (code pays fourni par la source)

Phase II Trial of First-Line Durvalumab and Chemotherapy in Patients With Extra-Pulmonary Small Cell Carcinoma

Peey-Sei Kok, Bryan Chan, Mason Aberoumoud, Alison Zhang et autres

Introduction: Prospective randomized trials are lacking in extensive-stage or metastatic extra-pulmonary small cell carcinoma (EPSCC). As a result, treatment for EPSCC is largely extrapolated from SCLC studies. Methods: This single-arm phase II trial enrolled patients with EPSCC to investigate the activity of …

au (code pays fourni par la source)

Reading "Chinese Cuisine": Culture and Development in the Chinese Catering Industry, 1980s - 2000s

Alison Zhang